NCT00688675View on ClinicalTrials.gov

Gastroesophageal Reflux Disease (GERD) Segmentation: Document How Swiss General Practitioners (GPs) Allocate Their GERD Patients to the Three GERD Patient Segments

CompletedOBSERVATIONAL
Enrollment

2,912

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
GERD
Trial Locations (1)

Unknown

Research Site, Aarau

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT00688675 - Gastroesophageal Reflux Disease (GERD) Segmentation: Document How Swiss General Practitioners (GPs) Allocate Their GERD Patients to the Three GERD Patient Segments | Biotech Hunter | Biotech Hunter